Latest / The Best of the Money Show / SA pharma sector welcomes 2.88% medicine price hike
Transcript
- 0:00Speaker 1: Well, we start with the latest price increases in the
- 0:02Speaker 1: health sector. The health department today issuing what's called an
- 0:04Speaker 1: extraordinary increase in the single exit price of all registered medicines.
- 0:08Speaker 1: They go up by nearly 3%. That's on top of
- 0:11Speaker 1: the increase that was already allowed in the ordinary course
- 0:16Speaker 1: earlier in the year. Meanwhile, Discovery Health, their count for
- 0:19Speaker 1: around 58% of all members of open medical schemes today
- 0:23Speaker 1: announcing their price increases for next year will range from 7.4%
- 0:25Speaker 1: to 8.9%.
- 0:25Speaker 2: We start.
- 0:29Speaker 1: With Dr. Stavros Nikolaou, the chair of the pharmaceutical action
- 0:33Speaker 1: group Farmisa. Stavros, good evening and thanks for your time.
- 0:36Speaker 1: Your sector asked for the second increase. What's been pushing
- 0:40Speaker 1: your costs up so dramatically?
- 0:41Speaker 2: Stephen Tversky, good evening and wonderful to be back on
- 0:46Speaker 2: your show again. The single exit price, as it's known,
- 0:52Speaker 2: pertains to the private sector and it is an annual
- 0:57Speaker 2: review We received as a pharmaceutical industry our single exit
- 1:02Speaker 2: price adjustment on 1 January 2026, beginning of the year,
- 1:08Speaker 2: and we received 1.47% increase. I should point out at
- 1:14Speaker 2: the time that inflation CPI was sitting at 3.3%. So
- 1:19Speaker 2: there was a degree of anxiety from the industry already
- 1:23Speaker 2: at that point in time because we had received less
- 1:26Speaker 2: than half of what inflation was sitting at at the time.
- 1:30Speaker 2: As matters got worse in March, when we started seeing
- 1:34Speaker 2: the first manifestations of the Straits of Hormuz crisis and
- 1:39Speaker 2: the Gulf oil crisis, and costs started spiraling upwards. These
- 1:44Speaker 2: are input costs. These are the costs to manufacture the medicines.
- 1:49Speaker 2: And independent studies demonstrate that input costs have gone up
- 1:54Speaker 2: in some cases by 30 to 40%. So we faced
- 1:57Speaker 2: an unsustainable situation. Inflation kept creeping up. It's sitting at
- 2:03Speaker 2: around 3.6% at the moment or there or thereabouts. And 1.47%
- 2:09Speaker 2: was highly inadequate. It meant that in some cases, manufacturers
- 2:15Speaker 2: were unable to supply medicines, which is not good for patients.
- 2:19Speaker 2: So the worst form of access is when you can't
- 2:21Speaker 2: supply medicines. So we did appeal to the National Health
- 2:27Speaker 2: Department and they, as you correctly stated earlier, they agreed
- 2:34Speaker 2: to a 2.88% further increase. Now that 2.88% is not
- 2:39Speaker 2: whole because it only applies for October, November and December.
- 2:44Speaker 2: But the crisis has been going on since March So
- 2:48Speaker 2: if you are to tally up the total here, you
- 2:51Speaker 2: actually come out at 2.1%. How did I get there?
- 2:54Speaker 2: It's the initial 1.47% plus three months of 12 months
- 2:56Speaker 2: of 2.88% gives you 2.1%. So still way below inflation,
- 2:58Speaker 2: but it does provide some relief. And we'll also, I think,
- 3:13Speaker 2: restore some of the medicines that are currently not in
- 3:17Speaker 2: supply because of the pricing and margin pressures.
- 3:21Speaker 1: You're still three months away from the 1st of January
- 3:24Speaker 1: next year. Fuel costs, at least, I'm sure, are probably
- 3:28Speaker 1: going to stay high until then. Will you be able
- 3:31Speaker 1: to get to the 1st of January? And could that
- 3:33Speaker 1: increase now have to be much higher than the health
- 3:35Speaker 1: department might have liked?
- 3:39Speaker 2: Look, I think that 2.88% or 2.9%, let me round
- 3:44Speaker 2: it off, is very much an interim relief. The problem
- 3:49Speaker 2: doesn't go away in its entirety, and we do face
- 3:53Speaker 2: a new single exit price adjustment on 1 January. We
- 3:58Speaker 2: are engaging the department. There's a pricing committee that we
- 4:01Speaker 2: engage in. What do we seek as an industry? Because
- 4:04Speaker 2: we're very sensitive to finding the balance between medicine access
- 4:10Speaker 2: on the one hand and patients accessing medicine sustainably. But
- 4:14Speaker 2: on the other hand, also a viable industry that's able
- 4:17Speaker 2: to continue supplying medicine. So we're very sensitive to finding
- 4:21Speaker 2: that balance. And for the moment, we think that balance
- 4:25Speaker 2: sits somewhere at the CPI levels. Obviously, if we experience
- 4:30Speaker 2: extraordinary events again, whatever those might be, and they're usually
- 4:35Speaker 2: geopolitical in nature, then we should have the opportunity to
- 4:40Speaker 2: go back to the department again. So what do we
- 4:42Speaker 2: favor for next year? We're being reasonable. We understand the
- 4:46Speaker 2: inflationary pressures. We understand households are under pressure. And we
- 4:51Speaker 2: think that a CPR-related increase with any potential shock absorbers
- 4:59Speaker 2: is the way to go. And it strikes the balance
- 5:01Speaker 2: that we're seeking here between access and sustainable supply. Dr.
- 5:05Speaker 1: Stavros Nikolaou, thank you very much indeed. The chair of
- 5:08Speaker 1: the industry group Farmisa, really do appreciate the time.